The electrophysiological and pharmacological properties of Ca 2+ current (I Ca ) were determined by the whole-cell configuration of the patch-clamp technique in smooth muscle cells from human umbilical artery. Using 5 mM extracellular Ca 2+ , depolarizing step pulses from -60 to 50 mV from a holding membrane potential of -80 mV evoked an I Ca which activated at membrane potentials more positive than -50 mV and exhibited a maximum current density in a range of 10-20 mV. Steady-state inactivation protocols using a V test of 10 mV gave a voltage at onehalf inactivation and a slope factor of -35.6 mV and 9.5 mV, respectively. Nifedipine (1 µM), an L-type Ca 2+ channels antagonist, completely inhibited I Ca , while the L-type Ca 2+ channels agonist Bay-K 8644 (1 µM) significantly increased I Ca amplitude. Moreover, the selective blocker of P-/Q-type Ca 2+ channels ω-agatoxin IVA partially blocked I Ca (about 40 % inhibition at +20 mV by 20 nM). These pharmacological results suggest that L-and P-/Q-type Ca 
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Introduction
Vascular smooth muscle tone is regulated by different mechanisms. One of the most important is the degree of Ca 2+ permeability of the plasma membrane which is determined by the presence of several Ca 2+ entry pathways. It has been demonstrated that low-and highvoltage-activated Ca 2+ channels (LVA and HVA, 56 respectively) are expressed in different kinds of vascular smooth muscle cells. Different pore-forming α subunits have been cloned and expressed in heterologous systems observing that alternative splicing exons and coexpression with α 2 δ, γ and β subunits, play important regulatory roles in the properties of functional Ca 2+ channels in native cells [1, 2] .
Among the HVA Ca 2+ channels family, the dihydropyridine-sensitive L-type Ca 2+ channels are, by far, the most studied [3] [4] [5] [6] . However, other members of the HVA Ca 2+ channels family, the P-/Q-type Ca 2+ channels, have been recently described in rat vascular smooth muscle cells, having a functional role in renal afferent arterioles [7] . Regarding the LVA Ca 2+ channels, the presence of the T-type Ca 2+ channels has been reported in several vessels [4, [8] [9] [10] [11] .
The study of the presence of different types of voltage-activated Ca 2+ channels, and their electrophysiological and pharmacological properties, in human vascular smooth muscle cells is important to increase the knowledge of Ca 2+ pathways that could be involved in contractile responses induced by changes in cell membrane potential or other vasoactive stimuli that can affect their activity. Nevertheless, the vast majority of reports in the literature regarding Ca 2+ channels involve non-human vessels or cultured cells, and the information about human vascular smooth muscle is scant. In particular, P-/Q-type Ca 2+ channels have not yet been described, to the best of our knowledge, in human vessels.
We focused our attention in Ca 2+ channels of the human umbilical artery (HUA). In this vessel, there are some reports showing the effects of Ca 2+ channels antagonist on arterial contractility [12, 13] , and we have also reported that nifedipine induced a complete relaxation of HUA rings contraction induced by a depolarizing high K + solution [14] . However, there is no information regarding neither the electrophysiological characteristics nor the molecular structure of voltage-activated Ca 2+ channels expressed in this artery.
In this work, we show for the first time the electrophysiological and pharmacological properties of voltage-activated whole-cell Ca 2+ current in HUA smooth muscle cells, which suggest that L, P-/Q-and T-type Ca 2+ channels are present is this vessel. Additionally, the presence of the α subunit of the P-/Q-type Ca 
Materials and Methods
Cell isolation procedure Umbilical cords obtained after vaginal and cesarean delivery were placed in saline solution containing (in mM): 130 NaCl, 4.7 KCl, 1.17 KH 2 PO 4 , 1.16 Mg SO 4 , 24 NaHCO 3 , 2.5 CaCl 2 , pH 7.4 at 4°C and immediately transported to our laboratory and stored at 4°C. The arteries were dissected from the Wharton´s jelly just before the cell isolation procedure. HUA smooth muscle cells were obtained by a method based on the one described by Klockner [15] and later modified in our laboratory in order to diminish the enzyme content in the dissociation medium (DM) [14] . Briefly, a segment of HUA was cleaned of any residual connective tissue, cut in small strips and placed for 15 min in a DM containing (in mM): 140 NaCl, 5 KH 2 PO 4 , 5 MgCl 2 , 20 glucose, 5 HEPES, pH was adjusted to 7.4 with NaOH. The strips were then placed in DM with 2 mg/ml collagenase type I during 25 min, with gentle agitation, at 35°C. After the incubation period the strips were washed with DM and single HUA smooth muscle cells were obtained by a gentle dispersion of the treated tissue using a Pasteur pipette. The remaining tissue and the supernatant containing isolated cells were stored at room temperature (~20°C) until used.
Patch-clamp recordings
HUA smooth muscle cells were allowed to settle onto the coverglass bottom of a 0.5 ml experimental chamber. The cells were observed with a mechanically stabilized, inverted microscope (Telaval 3, Carl Zeiss, Jena, Germany) equipped with a 40X objective lens. The chamber was perfused for 15 min, at 0.5 ml.min -1 by gravity, with the extracellular saline solution (ESS, see composition later) before the patch-clamp experiment was started. Application of test solutions was performed through a multibarreled pipette positioned close to the cell investigated. After each experiment on a single cell, the experimental chamber was replaced by another one containing a new sample of cells. Only well-relaxed, spindle-shaped smooth muscle cells were used for electrophysiological recordings. Data were collected within 4-6 h after cell isolation. All experiments were performed at room temperature (~20°C).
The standard tight-seal whole-cell configuration of the patch-clamp technique [16] was used. Glass pipettes were drawn from WPI PG52165-4 glass on a two-stage vertical micropipette puller (PP-83, Narishige Scientific Instrument Laboratories, Tokyo, Japan) and pipette resistance ranged from 2 to 4 MΩ measured in ESS. Ionic currents were measured with an Axopatch 200A amplifier (Axon Instruments, Foster City, CA). Whole-cell currents were filtered at 2 kHz, digitized (Digidata 1200 Axon Instruments, Foster City, CA) at a sample frequency of 100 kHz, except in the case of the steady-state inactivation protocols in which the sampling frequency was 20 kHz. The experimental recordings were stored on a computer hard disk for later analysis. Whole-cell capacitance was compensated electronically in most cells. In all cells whole-cell current was controlled applying test voltage steps during a short stabilization period discarding those in which the current amplitude did not remain constant with time.
Solutions
The ESS used for recording whole-cell ionic currents contained (in mM): 116 NaCl, 4.7 KCl, 5 CaCl 2 , 6 glucose, 5 HEPES, 10 tetraethylammonium (TEA); pH was adjusted to 7.4 with NaOH. In some experiments we used a CaCl 2 concentration of 30 mM while NaCl was adequately diminished to maintain the solution osmolarity. An identical ESS but containing 30 mM of BaCl 2 instead of CaCl 2 was also used.
The composition of the intracellular pipette solution (IPS) was (in mM): 120 CsCl, 5 Na 2 ATP, 1 MgCl 2 , 10 glucose, 10 EGTA, 20 HEPES; pH was adjusted to 7.3 with CsOH.
SDS-PAGE and Immunoblot Analysis
Human umbilical arteries were isolated as described above. Endothelial layer was eliminated mechanically. Smooth muscle proteins were extracted with 20 mM Tris-HCl, 8 M Urea, 1% SDS, pH 7.5 and were resolved by sodium dodecylsulphatepolyacrylamide gel (6%) electrophoresis (SDS-PAGE) followed by transfer to nitrocellulose membranes (Schleicher & Schuell Bioscience, Inc., USA). The membranes were stained with Ponceau S to monitor protein loading prior to immunodetection. Nitrocellulose membranes were first blocked with 3 % (w/v) non-fat milk for 1 h at 37°C. After several washes, the membranes were incubated overnight at 4°C with rabbit antibodies against α1A subunit of the P-/Q-type Ca 2+ channel at a dilution of 1:500 (Alomone Labs, Jerusalem, Israel). Subsequently, the membranes were incubated with horseradishconjugated anti-rabbit secondary antibody, and immunoreactive signals were detected with luminol followed by an exposure to X-ray film (Kodak, USA). The experiments were repeated after blocking the primary antibodies by pretreatment with a control peptide provided by the manufacturer.
Reagents
Collagenase type I (used for cell isolation), ethylene glycol-bis(β-aminoethyl ether) N,N,N',N',-tetraacetic acid (EGTA), CsCl, Na 2 ATP, nifedipine, Ponceau S and luminol were purchased from Sigma-Aldrich (St Louis, MS, USA), and (±) Bay-K 8644 and ω-agatoxin IVA were purchased from Alomone Labs. Ltd. (Jerusalem, Israel). All other reagents were of analytical grade and purchased from local vendors. Stock solutions of nifedipine and Bay-K 8644 were prepared in DMSO while ω-agatoxin IVA and mibefradil were dissolved in water. Fresh aliquots of stocks solutions were added to the different extracellular solutions on the day of the experiment. The final maximal concentration of DMSO in the solutions used for current measurements was very low (0.05%), and data from the literature show that even greater concentrations (0.1%) of DMSO did not affect calcium currents [17, 18] .
Statistics
The results are expressed as means ± SEM. Paired or unpaired Student's t-tests were used to establish statistically significant differences between two groups. The level of statistically significant differences was set to p<0.05.
Ethical considerations
The collection of umbilical cords was authorized by the Ethics Committee of the Hospital General Interzonal de Agudos Gral. San Martin of La Plata, and the patients were informed that the umbilical arteries would be used for scientific research. The experimental protocols were approved by the Scientific Committee of our institution.
Results
To study the presence of voltage-activated Ca 2+ channels in freshly dispersed smooth muscle cells from HUA, whole-cell currents were recorded using a high Figure 1A shows typical whole-cell Ca 2+ currents (I Ca ) evoked by a voltageclamp protocol applying 10 mV increase voltage-steps from -60 to 50 mV using a membrane holding potential (HP) of -80 mV. The mean peak current-voltage (I-V) relationship obtained from 50 smooth muscle cells of 18 different HUA samples is depicted in figure 1B . I Ca begins to activate at membrane potential (V m ) values more positive than -50 mV (range -40 to -30 mV among different cells), it presents a maximum current density at a value between 10 and 20 mV, and an extrapolated reversal potential of approximately 60 mV. When I-V curves were obtained using a more depolarized membrane HP (-40 mV) the threshold of activation for I Ca was around -20 mV, its maximum at membrane potentials between 10 and 20 mV, and its peak amplitude was significantly lower at all V m tested compared to I-V curves obtained in the same cells using a membrane HP of -80 mV (figure 1C). Figure 2A shows typical examples and the relationships between these parameters and the V m , where it is possible to observe that while τ activation decreased when V m became more depolarized, τ inactivation was voltage-independent up to 0 mV, while finally increased between 0 and 40 mV.
Steady-state inactivation of I Ca was determined using a standard two-pulse protocol, with a membrane HP of -80 mV and a test potential (V test ) of 10 mV. 4-secondsconditioning pulses from -100 mV to 10 mV (10 mV steps at 0.1 Hz) were applied before the test potential to assess I Ca availability. Peak I Ca amplitude elicited by the test potential, expressed as a proportion of the maximal I Ca recorded, was plotted against the value of the conditioning potentials. A steady-state inactivation curve was obtained , where h is the fraction of current inactivated, V m is the membrane potential, V 1/2 is the voltage at one-half inactivation and k is the slope factor. The V 1/2 and k values obtained were -35.6 mV and 9.5 mV, respectively ( Figure 2B ), which is in agreement with the fact reported above ( figure 1C ) that when a membrane HP of -40 mV was used the peak currents obtained were about half of those registered using a membrane HP of -80 mV.
Nifedipine (1 µM), the commonly used L-type Ca 2+ channels antagonist, rapidly induced a complete inhibition of I Ca ( figure 3 A and B [19, 20] . Since P-/Q-type Ca 2+ channels, extensively described in neurons, have been found only recently in vascular smooth muscle cells [7] , we tested the effect of ω-agatoxin IVA, the selective blocker of P-/Q-type Ca 2+ channels, on I Ca in HUA smooth muscle cells observing that it was partially blocked: at 20 mV about 25% of the I Ca was inhibited by 10 nM of toxin, and the inhibitory effect was higher for toxin concentrations of 20 or 100 nM (figure 4). The effect was reversible in most cells when the toxin was used at 10 nM, while at 20 To verify by a non-pharmacological approach that P/Q-type Ca 2+ channel was present in human umbilical artery, immunoblots were performed using antibodies specific for mouse α1A subunit of the P-/Q-type Ca 2+ channel. Immunoblots of umbilical artery smooth muscle protein extracts gave rise to one band of the expected size [7] , which did not appear when the antibody was pretreated with the control peptide provided by the manufacturer ( Figure 4D ). Other proteins present in the extract were not recognized by the antibody, therefore reaction conditions were specific. The immunoblots were repeated a total of three times, always with the same results. Moreover, similar results were also obtained (data not shown) using the same protocol with primary antibodies purchased from two other chemical companies (Sigma-Aldrich, St Louis, USA; and Santa Cruz Biotechnology Inc., Santa Cruz, USA, which required an anti-goat secondary antibody).
Regarding the contribution of a LVA T-type Ca 2+ current (I CaT ) to total I Ca in HUA smooth muscle cells, in the present recording conditions (5 mM extracellular Ca 2+ ) we did not observe a T-type component in I Ca neither by changing the membrane HP nor after nifedipine addition. First, and as it was shown in figure 1C , the change in membrane HP from -80 to -40 mV produced a decrease of the I Ca elicited by all the membrane potentials tested, preventing the observation of a selective effect of membrane HP on a putative LVA Ca 2+ current; and second, nifedipine completely blocked I Ca .
However, Smirnov & Aaronson [4] found that in human mesenteric artery cells there was a relatively small I CaT which proved difficult to detect when cells were superfused with solutions containing low millimolar concentrations of divalent cation charge carrier, so we also tested the pharmacological profile of I Ca using a high concentration (30 mM) of Ca pathways. Although L-and, to some extent, T-type Ca 2+ channels were expected to appear, the presence of P-/ Q-type Ca 2+ channels is an important novelty, since, to the best of our knowledge, there are no previous reports of these channels in human vascular smooth muscle.
The electrophysiological and pharmacological results suggest that in HUA L-and P-/Q-type Ca concentration. As nifedipine (1 µM) completely blocked I Ca , while ω-agatoxin IVA, the selective blocker of P-/Q-type Ca 2+ channels, inhibited about 40% of total current, we can suggest that L-and P-/Q-type Ca 2+ channels, both sensitive to dihydropyridines, elicited the total I Ca . Dihydropyridinesensitive P-/Q-type Ca 2+ channels have been observed in other cells, such as rat melanotropic cells [19] , and rat neurons [20] . Moreover, Hansen and coworkers [7] clearly described in a recent paper the presence and the functional role of P-/Q-type Ca 2+ channels in rat vascular smooth muscle, and they discussed the fact that if dihydropyridines are able to inhibit P-/Q-type Ca 2+ channels, there exists the possibility that the role of Ltype Ca 2+ channels has been overestimated and, as they indicate, the effects of therapeutic concentrations of dihydropyridines could involve blockage of both types of Ca 2+ channels. In agreement with this idea, our results show that in HUA smooth muscle cells nifedipine, used at a concentration commonly used to demonstrate the presence of L-type Ca 2+ channels, blocked the whole of I Ca , masking the presence of other types of channels, as the P-/Q-type, which were afterwards put in evidence using a specific toxin and whose expression was confirmed by immunoblotting. This could clearly lead to an overestimation of the role of L-type channels in this vessel.
When the concentration of divalent ion carrier was increased in the extracellular solution, it was possible to put in evidence a nifedipine-insensitive I Ca , as other authors have reported in human vascular smooth muscle cells [4] , which was completely blocked by 10 µM mibefradil. This current, likely a T-type Ca 2+ current, is detectable at V m positive to -50 mV and the maximum peak current variably lies between -20 and 10 mV depending on the ion current carrier. The electrophysiological characteristics of this I Ca share some of the properties described in the literature for T-type Ca 2+ currents in vascular and nonvascular smooth muscle cells [11] . In particular, the activation and inactivation parameters of this I Ca were in the range of values described in the literature for T-type currents registered in arterial smooth muscle cells where generally the presence of a tiny LVA Ca 2+ current has been reported [11] .
The channels, at least in neurons [22] and chromaffin cells [23] .
Physiological relevance of these results
As voltage-activated Ca 2+ channels represent important pathways for Ca 2+ influx in smooth muscle cells, and we are interested in the mechanisms of intracellular Ca 2+ regulation in human umbilical artery, we first studied the properties of these channels with the aim of characterizing them to further study their role in the regulation of the contractile state of this vessel. Several contractile evidences have been reported with respect to dihydropyridine effects on HUA. Belford and coworkers [12] have reported that dihydropyridines were potent vasodilators of HUA rings precontracted with high-K + solutions, nifedipine being the most potent (it reached a maximum effect at a concentration of 1 µM). Nifedipine at 3 µM completely inhibited bupivacaine-induced twitches in HUA, while a tonic tone persisted in its presence [13] . Moreover, Gopalakrishnan and coworkers [24] showed that Bay-K 8644 caused a dose-dependent increase of tone in the HUA. Our results are in agreement with these findings, because recording in a low Ca 2+ concentration (not so far from the physiological one) 1 µM nifedipine completely blocked, and Bay-K 8644 significantly increased, the macroscopic voltage-activated Ca 2+ current in isolated smooth muscle cells from HUA. However, our results also show that nifedipine at 1 µM is able to block two different populations of Ca [7] have demonstrated in rat renal afferent arterioles that ω-agatoxin IVA induced a partial blocking effect on total whole-cell Ca In this work we show that in HUA smooth muscle cells a T-type Ca 2+ current sensitive to mibefradil could be elicited by depolarization of membrane potential, although it was put in evidence in a high-Ca 2+ or highBa 2+ extracellular solution, a condition, nevertheless, used in several reports of Ca 2+ channels in vascular smooth muscle [11] . At present, we can only speculate about their importance in HUA smooth muscle cells and further studies will be conducted to establish their possible function in this vessel. Up to now, T-type Ca 2+ channels have been implicated in different roles in vascular smooth muscle, for instance, control of cell proliferation in human pulmonary artery [25] , regulation of myogenic tone in rat skeletal muscle resistance arteries [10] , and serving as Ca 2+ entry routes required for activation of high conductance Ca 2+ -activated potassium channels (BK Ca ) in mouse coronary arteries [26] .
Taken together, our results open a field of future research about the role of the different Ca 2+ channels in the regulation of contractility of HUA and consequently in the regulation of feto-placental circulation. They could constitute different targets for endogenous or exogenous agonists that modulate the intracellular Ca 2+ concentration and hence the vessel tone.
